SGLT2 Inhibition: Uric Acid Excretion Study

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The current study investigates the effects of SGLT2 inhibitor empagliflozin on uric acid excretion.
Epistemonikos ID: 8b3cbea9ec36062a34c281df8c6212b4f5462849
First added on: May 10, 2024